HCR 176 Hawaii House · 2026 Regular Session

REQUESTING THE DEPARTMENT OF EDUCATION TO ADOPT POLICIES AND PROCEDURES REGARDING THE STORAGE AND ADMINISTRATION OF ORAL ANTIHISTAMINES IN PUBLIC SCHOOLS.

This bill requests the Hawaii Department of Education to create clear policies for storing and administering oral antihistamines in public schools. It directly affects students with allergies, school staff, and parents by establishing a framework for managing mild allergic reactions during the school day. The key provisions require schools to have written parental consent, individualized physician-approved allergy plans, and trained personnel who can recognize allergy symptoms and properly administer the medication. The resolution also asks the Department to develop standardized forms for consent and protocols, and to report back to the Legislature within 20 days of the 2027 session with findings and any proposed legislation.

Issues: ✓ Education ✓ Healthcare

Bill status passed 3 of 5 stages cleared

Introduction

Mar 2026

Committee Review

Apr 2026

House Passage

Apr 2026

Senate Passage

Governor

Introduced Mar 16, 2026 Last action Apr 2, 2026

Maddy AI version diff · 1 comparison

What changed between versions

HCR176 → HCR176_HD1 · 3 edits

MINOR

The bill was amended to clarify that the Department of Education must adopt policies for a specific, individualized, physician-directed allergy response protocol. This change ensures that schools can only use oral antihistamines if a doctor has explicitly authorized their use for a specific student, rather than relying on a general protocol. The amendment also updated the document's versioning and formatting details to reflect its status as a House Draft.

Scope change

The scope of the required protocol was narrowed and clarified to mandate individualized plans with explicit physician authorization for each student, rather than a general file.

REQUIREMENT

Changed the requirement for an allergy response protocol from a general file to a 'current, individualized, physician-directed' plan that explicitly authorizes oral antihistamines.

TECHNICAL

Updated document metadata, including the title to 'HCR176 HD1', file names, and revision numbers to reflect the House Draft status.

Adjusted the document's page count and line numbers to match the new template format.

Floor votes

How they voted

This bill passed the House by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 2, 2026

Lower · Passed

Report adopted; referred to the committee(s) on FIN as amended in HD 1 with none voting aye with reservations; none voting no (0) and none excused (0).

lower

Apr 2, 2026

Committee

Reported from EDN (Stand. Com. Rep. No. 1777-26) as amended in HD 1, recommending referral to FIN.

lower

Mar 31, 2026

Lower · Passed

The committee on EDN recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 6 Ayes: Representative(s) Woodson, La Chica, Amato, Evslin, Kapela, Olds; Ayes with reservations: none; Noes: none; and 4 Excused: Representative(s) Garrett, Kila, Muraoka, Souza.

lower

Mar 18, 2026

Committee

Referred to EDN, FIN, referral sheet 19

lower

Mar 16, 2026

Introduced

Offered

lower

4 primary · 0 co-sponsors